Systemic mexiletine relieves chronic allodynialike symptoms in rats with ischemic spinal cord injury.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 1567030.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We have recently reported a chronic allodynialike symptom in rats after ischemic spinal cord injury. This pain-related behavior is resistant to a number of pharmacologic treatments, including morphine, clonidine, carbamazepine, baclofen, and muscimol. In the present report, we present evidence indicating that systemic mexiletine, a local anesthetic and antiarrhythmic agent, effectively relieves the allodynia-like symptoms at doses of 15 and 30 mg/kg in these rats without inducing major side effects. It is suggested that systemically applied mexiletine may be useful in treating central pain in patients with spinal cord injury.
Medical subject headings
- Ischemia
- Mexiletine
- Pain
- Spinal Cord Injuries